尊龙凯时人生就是博·官方(中国)
Home
About Us
About Us
Executive team
Corporate Structure
Brand
Our History
Our Culture
Contact us
News Releases
Business
R&D
Manufacturing
Distribution
Career
Talent concept
Cultivation of talents
Social Responsibility
Responsibility Management
Sustainability Report
CSR News
Investor Relations
Corporate Governance
Announcements
Financial Reports
Company Presentations
Stock Price
Analyst Coverage
Investor Relations Contacts
CN
EN
Home
About Us
About Us
Executive team
Corporate Structure
Brand
Our History
Our Culture
Contact us
News Releases
Business
R&D
Manufacturing
Distribution
Career
Talent concept
Cultivation of talents
Social Responsibility
Responsibility Management
Sustainability Report
CSR News
Investor Relations
Corporate Governance
Announcements
Financial Reports
Company Presentations
Stock Price
Analyst Coverage
Investor Relations Contacts
CR Home
中文版
Search
News Releases
Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs
News Releases
more >
Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and Efficacy of Generic Drugs
01-22
Novel Cancer Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone and CR Double-Crane Convened
11-12
NIP Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC
10-09
A Delegation Led by Zhang Boli Visiting CR Sanjiu
10-08
Remaining Committed to Charity - The CR Healthy Village Program Keeping up the Good Work
09-17
CR Double-Crane’s Sodium Valproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs
08-04
more >
Investor Announcement
more >
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
03-27
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
03-27
PRINCIPAL FINANCIAL INFORMATION OF JIANGZHONG PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2024
03-20
PRINCIPAL FINANCIAL INFORMATION OF CR DOUBLE-CRANE FOR THE YEAR ENDED 31 DECEMBER 2024
03-20
PRINCIPAL FINANCIAL INFORMATION OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2024
03-19
PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2024
03-18
PRINCIPAL FINANCIAL INFORMATION OF DONG-E-E-JIAO FOR THE YEAR ENDED 31 DECEMBER 2024
03-18
more >
Video Center
您的浏览器不支持 video 标签。
Back to Top
Contact us
|
site map
|
Disclaimer
|
Privacy Policy
Copyright © China Resources Pharmaceutical Group Limited
京ICP备17049899号 京公网安备11010502056191号
Technical Support:CR DIGITAL
Copyright © China Resources Pharmaceutical Group Limited
京ICP备17049899号
京公网安备11010502056191号
Technical Support:CR DIGITAL
返回到首页
Back to Top